mixed-mode probability
NORC (AmeriSpeak)
KFF/The Washington Post Trans Survey · Nov 10, 2022 – Dec 2022 · US national
Methodology
- Pollster
- NORC (AmeriSpeak) media
- Sponsor
- KFF / The Washington Post
- Commissioned by
- KFF and The Washington Post
- Fielded
- Nov 10, 2022 – Dec 2022
- Population
- adults (with an oversample of transgender adults)
- Sample size
- 1,338
- Sample frame
- mixed-mode probability
- Panel
- SSRS Opinion Panel; Gallup Panel; NORC AmeriSpeak
- Mode
- mixed mode - general-population comparison sample (n=823 cisgender adults) from the SSRS Opinion Panel, online (n=784) and by phone for non-internet panelists (n=39); trans oversample (n=515) recruited from three probability panels (Gallup Panel n=252, NORC AmeriSpeak n=146, SSRS Opinion Panel n=85) plus callbacks to prior KFF and SSRS Omnibus respondents who identified as LGBT
- Margin of error
- +/- 4 percentage points for total adults; +/- 7 percentage points for trans adults (design effect included)
- Weighting
- trans sample weighted to CDC BRFSS and Williams Institute small-area estimates of the U.S. trans adult population on age, education, race/ethnicity and region; full adult sample weighted to 2021 CPS on sex, age, education, race/ethnicity and region, plus civic engagement (CPS Sept 2019 supplement) and frequency of internet use (Pew NPORS)
- Geography
- US national
- Base notes
- n=1,338 total adults (823 cisgender + 515 trans adults); the trans adults are reported separately as well as folded into the total-adult figures. MOSE +/-4 for total adults and cisgender adults, +/-7 for trans adults.
Sources
Verification note. Topline PDF downloaded and text-extracted in session; Q31 and Q32 wording, item text, and the Total adults / Total trans adults rows read directly. Party breaks are not published in this topline.
Figures below are transcribed from these documents. Where they disagree with the source, the source governs.
Questions asked (4)
AGES 10-14; gender-affirming COUNSELING OR THERAPY; ACCESS framing; 'under medical supervision' clause
Do you (support) or (oppose) trans children between the ages of 10 and 14 having access to gender-affirming counseling or therapy under medical supervision?
Wording notes: ACCESS framing (support = permit) | explicit narrow age band 10-14 | 'under medical supervision' clause supplies a clinical safeguard | calls the population 'trans children' | support/oppose terms rotated in the stem
neutral — Rotation of the support/oppose terms and an explicit age band make this one of the cleanest items in the corpus. Its value is as the top rung of a two-by-two design (age 10-14 vs 15-17 crossed with counseling vs medication) that isolates each factor.
Subgroup figures (2)
AGES 10-14; PUBERTY-BLOCKING MEDICATION; ACCESS framing; 'under medical supervision' clause
Do you (support) or (oppose) trans children between the ages of 10 and 14 having access to puberty-blocking medication under medical supervision?
Wording notes: ACCESS framing (support = permit) | explicit narrow age band 10-14 | 'under medical supervision' clause | names puberty-blocking medication specifically
neutral — Identical stem to Q31a with only the treatment swapped, which makes the 31-point drop (62% to 31% support) a clean treatment-name effect at a fixed age. Read together with Q32b it also isolates the age effect: puberty blockers at 10-14 draw 31% support while hormones at 15-17 draw 42%.
Subgroup figures (2)
AGES 15-17; gender-affirming COUNSELING OR THERAPY; ACCESS framing; 'under medical supervision' clause
Do you (support) or (oppose) trans teenagers, between the ages of 15 and 17, having access to gender-affirming counseling or therapy under medical supervision?
Wording notes: ACCESS framing (support = permit) | explicit age band 15-17 | 'under medical supervision' clause | calls the population 'trans teenagers' rather than 'children'
neutral — The word 'teenagers' replaces 'children' along with the age band, so age and label move together here; support rises only 4 points over the 10-14 counseling item.
Subgroup figures (2)
AGES 15-17; HORMONAL TREATMENTS; ACCESS framing; 'under medical supervision' clause
Do you (support) or (oppose) trans teenagers, between the ages of 15 and 17, having access to hormonal treatments under medical supervision?
Wording notes: ACCESS framing (support = permit) | explicit age band 15-17 | 'under medical supervision' clause | names hormonal treatments specifically | no surgery item was asked for minors
neutral — The most-cited number from this survey (58% oppose). Its pairing with Q31b is the strongest evidence in the file that the age threshold moves opinion independently of the treatment: medication support runs 31% at ages 10-14 and 42% at ages 15-17. Note this survey never asked about surgery for minors, so the very low surgery figures quoted elsewhere are not comparable to it.
Subgroup figures (2)